Pharmacology & ToxicologyASEAN Journal of PsychiatryPeer-reviewed
Leronlimab a humanized anti-CCR5 monoclonal antibody ameliorates hepatic fibrosis in two preclinical fibrosis mouse models
Melissa Palmer, Taishi Hashiguchi, Arvin Cyrus Arman…·Jacob Paul Lalezari
This study evaluates leronlimab's antifibrotic effects in two mouse models of liver fibrosis, showing significant reduction in fibrosis area with 10 mg/kg/week doses.
DOI 10.54615/2231-7805.26.15.281